Cargando…
TARP as antigen in cancer immunotherapy
In recent decades, immunotherapy has become a pivotal element in cancer treatment. A remaining challenge is the identification of cancer-associated antigens suitable as targets for immunotherapeutics with potent on-target and few off-tumor effects. The T-cell receptor gamma (TCRγ) chain alternate re...
Autores principales: | Vanhooren, Jolien, Derpoorter, Charlotte, Depreter, Barbara, Deneweth, Larissa, Philippé, Jan, De Moerloose, Barbara, Lammens, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164403/ https://www.ncbi.nlm.nih.gov/pubmed/34050774 http://dx.doi.org/10.1007/s00262-021-02972-x |
Ejemplares similares
-
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023) -
Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
por: Depreter, Barbara, et al.
Publicado: (2020) -
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020) -
Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia
por: Vanhooren, Jolien, et al.
Publicado: (2022) -
Genes at the Crossroad of Primary Immunodeficiencies and Cancer
por: Derpoorter, Charlotte, et al.
Publicado: (2018)